脑心轴:神经刺激技术在缺血性心脏病 (综述) 中
Yunnan Liu1, Haimei Yang2, Jian Xiong1
1The Acupuncture and Massage Institute of Chengdu University of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610075, P.R. China.
International journal of molecular medicine
|July 19, 2025
概括
缺血性心脏病 (IHD) 涉及到大脑-心脏轴. 针对自主功能障碍的神经调制疗法为管理IHD和改善心血管健康提供了有希望的新途径.
科学领域:
- 心脏病学 心脏病学
- 神经科学是一个神经科学.
- 自主神经系统研究 自主神经系统研究
背景情况:
- 缺血性心脏病 (IHD) 是全球主要的死亡原因,通常源于动脉样硬化和冠状动脉微血管功能障碍.
- IHD可能导致严重的并发症,如心力衰竭,心律失常和心脏突然死亡,需要在后期阶段进行先进的治疗.
- 由自主神经系统介导的脑心轴在心血管调节和IHD进展中起着至关重要的作用.
研究的目的:
- 审查缺血性心脏病 (IHD) 的病理生理学.
- 检查神经系统在IHD发展和进展中的复杂作用.
- 探索神经调制疗法在治疗IHD中的潜力.
主要方法:
- 对IHD病理生理学和神经系统参与的现有文献进行系统审查.
- 分析自主神经系统失衡对心血管疾病的影响.
- 评估新兴的神经调制技术,包括脊髓和迷走神经刺激.
主要成果:
- 自主功能障碍,其特征是交感过度活跃和降低的副交感音调,通过促进炎症和血管收缩,加剧了IHD.
- 神经调节疗法在恢复自主平衡和增强心血管功能方面显示出潜力.
- 神经心脏界面是新型治疗干预的关键目标.
结论:
- 神经系统显著影响缺血性心脏病 (IHD) 的病理生理学.
- 神经调制疗法通过准脑心轴来治疗IHD是一个有希望的前沿.
- 需要进一步的研究,以解决目前的挑战和知识差距在神经调制的IHD管理.
相关概念视频
Ischemic Heart Disease: Overview
1.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
511
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
511


